Clinical Trial Update: Optimizing Propofol in Obese Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating optimal propofol dosing in obese patients undergoing hysterectomy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Hysterectomy | Phase 4 | Status: COMPLETED